Literature DB >> 7749870

Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness.

M R Adams1, J K Williams, J R Kaplan.   

Abstract

The factors responsible for the marked gender differences in risk of coronary heart disease and atherosclerosis severity remain largely undetermined. While some clinical and experimental evidence supports a protective effect of endogenous estrogen on the initiation and progression of atherosclerosis and incidence of coronary heart disease, much of the epidemiological data do not support this conclusion. The possibility that endogenous androgens may have adverse effects on atherosclerosis progression and coronary risk has received little attention. We investigated the effects of experimentally induced hyperandrogenism in female cynomolgus monkeys with diet-induced atherosclerosis. Animals were assigned randomly to one of four treatment groups: (1) untreated controls, (2) ovariectomized (sex hormone-deficient) controls, (3) treated with androstenedione and estrone (mild hyperandrogenism), or (4) treated with testosterone (male plasma androgen pattern). At necropsy, coronary atherosclerosis was approximately twice as extensive (P < .05) in testosterone-treated animals relative to untreated controls, while treatment with androstenedione and estrone had no effect on atherosclerosis extent. Coronary plaque size was positively correlated with lumen size in intact and ovariectomized controls; however, there was no evidence of a similar relation between animals in either androgen treatment group. The atherogenic effects of testosterone were independent of variations in plasma lipoprotein and nonlipoprotein risk variables. Although chronic hyperandrogenism had adverse effects on atherosclerosis progression, it reversed (P < .03) atherosclerosis-related impairment of endothelium-dependent vasodilator responses. We conclude that an experimentally induced male plasma androgen pattern results in exacerbation of diet-induced atherosclerosis-related arterial remodeling in female monkeys.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749870     DOI: 10.1161/01.atv.15.5.562

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

1.  Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries.

Authors:  H Teoh; A Quan; S W Leung; R Y Man
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis.

Authors:  Andrea Sansone; Giulia Rastrelli; Angelo Cignarelli; Maurizio de Rocco Ponce; Rosita Angela Condorelli; Elisa Giannetta; Elisa Maseroli; Sara Pinto; Ciro Salzano; Daniele Santi
Journal:  Int J Impot Res       Date:  2019-06-24       Impact factor: 2.896

3.  Evidence of proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Neal S Rote; Judi Minium; John P Kirwan
Journal:  Metabolism       Date:  2009-07       Impact factor: 8.694

Review 4.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

5.  Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone.

Authors:  V Brancaleone; V Vellecco; D S Matassa; R d'Emmanuele di Villa Bianca; R Sorrentino; A Ianaro; M Bucci; F Esposito; G Cirino
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

6.  Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis.

Authors:  Tapan K Mukherjee; Hillary Dinh; Gautam Chaudhuri; Lauren Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

7.  Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.

Authors:  Frank González; Neal S Rote; Judi Minium; Amy L Weaver; John P Kirwan
Journal:  Cytokine       Date:  2010-07-03       Impact factor: 3.861

8.  Sex steroids and heart rate variability in patients after myocardial infarction.

Authors:  Jerzy Krzysztof Wranicz; Marcin Rosiak; Iwona Cygankiewicz; Piotr Kula; Krzysztof Kula; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

9.  Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

10.  Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition.

Authors:  E Alvarez; E Cairrão; M Morgado; C Morais; I Verde
Journal:  Adv Pharmacol Sci       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.